Eli Lilly and Co (XSWX:LLY) Change In Inventory: CHF0 Mil (TTM As of Mar. 2026)


XSWX:LLY Eli Lilly and Co XSWX:LLY
100 GF Score
Price CHF970.00
GF Value CHF1,127.02
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eli Lilly and Co Change In Inventory?

Eli Lilly and Co XSWX:LLY 100 Change In Inventory is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:LLY with a GF Score™ of 100/100 and a GF Value™ of CHF1,127.02 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Eli Lilly and Co's change in inventory for the quarter that ended in Mar. 2026 was CHF0 Mil. It means Eli Lilly and Co's inventory stayed the same from Dec. 2025 to Mar. 2026 .

Eli Lilly and Co's change in inventory for the fiscal year that ended in Dec. 2025 was CHF-3,722 Mil. It means Eli Lilly and Co's inventory increased by CHF3,722 Mil from Dec. 2024 to Dec. 2025 .

Eli Lilly and Co's Total Inventories for the quarter that ended in Mar. 2026 was CHF11,439 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Eli Lilly and Co's Days Inventory for the quarter that ended in Mar. 2026 was 362.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. Eli Lilly and Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Eli Lilly and Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.72.

Eli Lilly and Co  (XSWX:LLY) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Eli Lilly and Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=11195.638/2816.172*365 / 4
=362.76

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Eli Lilly and Co's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=2816.172 / 11195.638
=0.25

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Eli Lilly and Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=11195.638 / 15587.753
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Change In Inventory Related Terms

Eli Lilly and Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Change In Inventory Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -217.26 -558.68 -1,232.34 -2,235.24 -3,722.32

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:LLY
100GF Score
Eli Lilly and Co XSWX:LLY
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of CHF0 Mil mean?
Eli Lilly and Co (XSWX:LLY) has a Change In Inventory of CHF0 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Change In Inventory too high?
Eli Lilly and Co's current Change In Inventory is CHF0 Mil. Overall, Eli Lilly and Co has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Change In Inventory compare to JNJ and ABBV?
Eli Lilly and Co's Change In Inventory of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Eli Lilly and Co and its competitors. Eli Lilly and Co's current Change In Inventory is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (XSWX:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF1,127.02, compared to a current price of CHF970.00 — trading 13.9% below its estimated fair value. The current Change In Inventory is CHF0 Mil. Eli Lilly and Co's overall GF Score™ is 100/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Eli Lilly and Co (XSWX:LLY), the current Change In Inventory is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (XSWX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of CHF970.00 is trading 13.9% below its estimated GF Value™ of CHF1,127.02. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for XSWX:LLY:

  • Change In Inventory: CHF0 Mil
  • GF Value™: CHF1,127.02 vs. price of CHF970.00 (13.9% below fair value)
  • GF Score™: 100/100 with 6 warning signs

No single metric tells the full story. See the XSWX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
100GF Score

Get the complete analysis for XSWX:LLY

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF970.00
Price
CHF1,127.02
GF Value